CAS 376348-65-1 appears in our catalog under these names: Maraviroc, Maraviroc, >95% (HPLC), Maraviroc/ 99.55% (existing batch purity), Maraviroc, >95.0%(HPLC)(qNMR), Maraviroc, 97.00%. Offered by: Chemat Brand, TRC, Mikromol, TargetMol, GLPBio. Available pack sizes: on request, 10mg, 25mg, 50mg, 250mg, 5mg, 100mg, 200mg.
Maraviroc is a monocarboxylic acid amide obtained by formal condensation of the carboxy group of 4,4-difluorocyclohexanecarboxylic acid and the primary amino group of (1S)-3-[(3-exo)-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropylamine. An antiretroviral drug, it prevents the interaction of HIV-1 gp120 and chemokine receptor 5 (CCR5) necessary for CCR5-tropic HIV-1 to enter cells. It has a role as an antiviral drug, a HIV fusion inhibitor and a chemokine receptor 5 antagonist. It is a monocarboxylic acid amide, a member of triazoles, an organofluorine compound and an azabicycloalkane.
Source: ChEBI
| Molecular formula | C29H41F2N5O |
|---|---|
| Molecular weight | 513.7 g/mol |
| IUPAC name | 4,4-difluoro-N-[(1S)-3-[(1S,5R)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide |
| InChIKey | GSNHKUDZZFZSJB-HLMSNRGBSA-N |
| SMILES | CC1=NN=C(N1C2C[C@H]3CC[C@@H](C2)N3CC[C@@H](C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C |
Computed by PubChem (NCBI)